Message: Return type of CI_Session_null_driver::open($save_path, $name) should either be compatible with SessionHandlerInterface::open(string $path, string $name): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::close() should either be compatible with SessionHandlerInterface::close(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::read($session_id) should either be compatible with SessionHandlerInterface::read(string $id): string|false, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::write($session_id, $session_data) should either be compatible with SessionHandlerInterface::write(string $id, string $data): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::destroy($session_id) should either be compatible with SessionHandlerInterface::destroy(string $id): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
Message: Return type of CI_Session_null_driver::gc($maxlifetime) should either be compatible with SessionHandlerInterface::gc(int $max_lifetime): int|false, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice
NRIPage | Articles | Dr Agarwal’s Healthcare IPO Listing on February 4 | Get Indian Desi Latest Political News & Updates in USA. Get domestic, republic government updates - NRI Page
Dr Agarwal’s Healthcare Ltd, a leading healthcare provider, is all set to list its shares on the stock exchanges on February 4. The company raised a significant amount of ₹3,027.26 crore through its initial public offering (IPO), which included both a fresh issue and an offer for sale. The IPO was open for subscription from January 29 to January 31, 2025, and the allotment was finalized on February 3. The IPO was priced between ₹382 and ₹402 per share, with investors eager to see how the stock performs upon listing.
The Dr Agarwal’s Healthcare IPO received a mixed response from investors, with an overall subscription of 1.55 times. Retail investors subscribed to 41% of the allotted portion, while non-institutional investors (NIIs) booked 40%. However, it was the Qualified Institutional Buyers (QIBs) segment that saw the most demand, with their portion subscribed a whopping 4.64 times. Despite the lukewarm response from retail and non-institutional investors, the QIB segment’s interest adds some optimism ahead of the listing.
Grey Market Premium (GMP) and Listing Expectations
Ahead of its listing, Dr Agarwal’s Healthcare shares are showing a muted trend in the grey market, with a GMP of ₹0 per share. This indicates that shares are being traded at the issue price with no significant premium or discount. Based on the lack of GMP, it is anticipated that the stock will list at ₹402 per share, which is at par with the issue price. Investors are closely watching the market reaction on listing day to see if the stock gains momentum post-debut.
Key IPO Details and Lead Managers
Dr Agarwal’s Healthcare’s IPO consists of a combination of a fresh issue of 74.62 lakh equity shares worth ₹300 crore and an offer for sale of 6.78 crore shares, raising ₹2,727.26 crore. Kotak Mahindra Capital Company, Morgan Stanley India Company, Jefferies India, and Motilal Oswal Investment Advisors are the book-running lead managers for this IPO, while Kfin Technologies is the registrar. The company will be listed on both the BSE and NSE, and investors are hoping for a stable listing despite the modest GMP.
